mitoxantrone has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We measured the percentage of Philadelphia chromosome (Ph)-negative cells in the autologous cells collected after conventional-dose chemotherapy-induced myelosuppression before autologous transplant and in the marrow of these same CML patients after autologous transplantation of these cells into recipients treated with the cyclophosphamide, VP-16, and TBI." | 1.29 | Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autolog ( Calvert, L; Claxton, D; Durett, A; Giralt, S; Hamer, J; Kantarjian, H; Khouri, I; Liang, J; Talpaz, M; Tibbits, P, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Talpaz, M | 1 |
| Kantarjian, H | 1 |
| Liang, J | 1 |
| Calvert, L | 1 |
| Hamer, J | 1 |
| Tibbits, P | 1 |
| Durett, A | 1 |
| Claxton, D | 1 |
| Giralt, S | 1 |
| Khouri, I | 1 |
| Visani, G | 1 |
| Rosti, G | 1 |
| Bandini, G | 1 |
| Tosi, P | 1 |
| Isidori, A | 1 |
| Malagola, M | 1 |
| Stanzani, M | 1 |
| Martinelli, G | 1 |
| Piccaluga, P | 1 |
| Testoni, N | 1 |
| Ricci, P | 1 |
| Tura, S | 1 |
| Nielsen, H | 1 |
| Nielsen, JL | 1 |
| Karle, H | 1 |
3 other studies available for mitoxantrone and Granulocytic Leukemia, Chronic, Stable Phase